[go: up one dir, main page]

NO20021830L - Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav - Google Patents

Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav

Info

Publication number
NO20021830L
NO20021830L NO20021830A NO20021830A NO20021830L NO 20021830 L NO20021830 L NO 20021830L NO 20021830 A NO20021830 A NO 20021830A NO 20021830 A NO20021830 A NO 20021830A NO 20021830 L NO20021830 L NO 20021830L
Authority
NO
Norway
Prior art keywords
symptoms
preventing
methods
flu
preparing
Prior art date
Application number
NO20021830A
Other languages
English (en)
Other versions
NO20021830D0 (no
Inventor
Paul John Rennie
Simon Philip King
Kimberly Ann Biedermann
Jeffrey Michael Morgan
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20021830D0 publication Critical patent/NO20021830D0/no
Publication of NO20021830L publication Critical patent/NO20021830L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
    • D21H27/30—Multi-ply
    • D21H27/32—Multi-ply with materials applied between the sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Detergent Compositions (AREA)
NO20021830A 1999-10-19 2002-04-18 Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav NO20021830L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42113199A 1999-10-19 1999-10-19
PCT/US2000/028856 WO2001028556A2 (en) 1999-10-19 2000-10-19 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use

Publications (2)

Publication Number Publication Date
NO20021830D0 NO20021830D0 (no) 2002-04-18
NO20021830L true NO20021830L (no) 2002-04-18

Family

ID=23669286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021830A NO20021830L (no) 1999-10-19 2002-04-18 Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav

Country Status (21)

Country Link
EP (2) EP1242073B1 (no)
JP (2) JP2003512323A (no)
KR (2) KR20020038945A (no)
CN (3) CN1411372A (no)
AT (1) ATE276749T1 (no)
AU (2) AU8029700A (no)
BR (1) BR0014778A (no)
CA (2) CA2382985A1 (no)
CZ (1) CZ20021374A3 (no)
DE (1) DE60014163T2 (no)
ES (1) ES2223601T3 (no)
HK (1) HK1050475A1 (no)
HU (1) HUP0204123A3 (no)
MX (1) MXPA02003882A (no)
NO (1) NO20021830L (no)
NZ (1) NZ518117A (no)
PL (1) PL199782B1 (no)
RU (1) RU2228177C2 (no)
TR (1) TR200201048T2 (no)
WO (2) WO2001028552A2 (no)
ZA (1) ZA200202475B (no)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US6436885B2 (en) * 2000-01-20 2002-08-20 The Procter & Gamble Company Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid
CN1395613A (zh) * 2000-01-20 2003-02-05 宝洁公司 抗微生物组合物
DE10065045A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
JP2009132734A (ja) * 2001-08-27 2009-06-18 Daiichi Sankyo Healthcare Co Ltd 抗感冒剤
JP4318899B2 (ja) * 2001-08-27 2009-08-26 第一三共ヘルスケア株式会社 抗感冒剤
DE10144235B4 (de) * 2001-09-08 2004-08-19 Beiersdorf Ag W/S-Emulsionen und deren Verwendung
US20030118620A1 (en) * 2001-09-12 2003-06-26 Unilever Home & Personal Care Usa, Division Of Conopco Inc. Thickener system for cosmetic compositions
US6806213B2 (en) 2001-12-20 2004-10-19 Kimberly-Clark Worldwide, Inc. Disposable wash cloth and method of using
BRPI0307550B8 (pt) 2002-03-12 2021-05-25 Galderma Res & Dev composição farmacêutica em gel tópica, de adapaleno 0,3%
JP2005530857A (ja) * 2002-06-21 2005-10-13 ザ プロクター アンド ギャンブル カンパニー 抗菌組成物、抗菌製品、及びそれらを使用する方法
US7569530B1 (en) 2003-06-20 2009-08-04 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
ATE463257T1 (de) * 2003-01-13 2010-04-15 Procter & Gamble Zusammensetzungen zur vorbeugung und behandlung von erkältung und influenza-ähnlichen erscheinungen enthaltend ausgewählte mukadhäsive polymere
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
JP4847756B2 (ja) * 2003-09-19 2011-12-28 大塚製薬株式会社 ヒトβディフェンシン分泌促進剤
US20050271711A1 (en) * 2004-04-26 2005-12-08 The Procter & Gamble Company Therapeutic antimicrobial compositions and methods
AU2005249572A1 (en) * 2004-06-02 2005-12-15 Neurogesx, Inc. Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
DE102004041333A1 (de) * 2004-08-20 2006-03-09 Dental-Kosmetik Gmbh & Co. Kg Zahngel
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
ES2310790T3 (es) * 2004-10-13 2009-01-16 The Procter And Gamble Company Dispositivo para suministrar una composicion antimicrobiana.
JP5642929B2 (ja) 2005-03-10 2014-12-17 スリーエム イノベイティブ プロパティズ カンパニー 微小生体汚染の低減方法
ATE511838T1 (de) 2005-03-10 2011-06-15 3M Innovative Properties Co Antimikrobielle zusammensetzungen mit hydroxycarboxylsäureestern
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
CZ299143B6 (cs) * 2007-03-06 2008-04-30 Ecoton S. R. O. Dezinfekcní prostredek
GB2456528B (en) * 2008-01-16 2012-08-22 Pangaea Lab Ltd Antioxidant for use in cosmetic, medicated and pharmaceutical compositions
ATE524160T1 (de) * 2008-02-14 2011-09-15 Kpss Kao Gmbh Haarpflegemittel enthaltend pca und pca-ester
US20110206790A1 (en) * 2008-10-30 2011-08-25 Ohso Clean, Inc Antimicrobial Foamable Soaps
MX2011004678A (es) * 2008-11-04 2011-10-11 Vymedic Llc Formulaciones complementarias antivirales.
JP5935689B2 (ja) * 2010-02-16 2016-06-15 味の素株式会社 ピロリドンカルボン酸またはその塩の製造方法
JP2013139391A (ja) * 2010-04-09 2013-07-18 Hokkaido Univ ウイルス感染抑制および／または感染症治療剤
US20110305651A1 (en) * 2010-06-15 2011-12-15 Conopco, Inc. D/B/A Unilever Sunless tanning compositions with nucleophile functionalized sulfonic acids
IT1400721B1 (it) * 2010-07-07 2013-06-28 Baldacci Lab Spa Composizioni a base di acido pirrolidoncarbossilico (pca) e sali metallici.
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
EP2760546B1 (en) 2011-09-26 2017-09-20 Unilever Plc. Hair composition
JP6100510B2 (ja) * 2011-11-16 2017-03-22 第一三共ヘルスケア株式会社 抗感冒剤
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
CN102560036A (zh) * 2012-01-17 2012-07-11 杭州百木表面技术有限公司 铜带退火防粘剂
CZ303941B6 (cs) * 2012-04-24 2013-07-03 Farmak Moravia, A.S. Dezinfekcní prípravek, jeho pouzití a zpusob dezinfekce
MY184460A (en) * 2012-11-08 2021-04-01 Lion Corp Oral composition and oral active oxygen scavenger
US20150030862A1 (en) * 2013-07-26 2015-01-29 United State Gypsum Company Mold-resistant paper and gypsum panel, antimicrobial paper coating and related methods
WO2015040642A1 (en) * 2013-09-19 2015-03-26 B.B.S. S.P.A. Process for the preparation of an antibacterial polymer material for food application
RU2555358C1 (ru) * 2014-06-06 2015-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Гель для душа
RU2577697C2 (ru) * 2014-12-26 2016-03-20 Анатолий Тимофеевич Корабельников Средство для избавления от полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
US10716305B2 (en) 2015-01-23 2020-07-21 Biocidium Biopharmaceuticals Inc. Anti-bacterial compositions
RU2626829C2 (ru) * 2015-11-02 2017-08-02 Анатолий Тимофеевич Корабельников Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
JP6465820B2 (ja) * 2016-01-15 2019-02-06 安井 敦司 抗菌・抗ウイルス性組成物およびこれを含む潤滑剤
JP6689613B2 (ja) * 2016-01-29 2020-04-28 株式会社Ｃｓｌ 繊維用抗菌・抗ウイルス性組成物および繊維製品
JP6317798B2 (ja) * 2016-10-19 2018-04-25 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
EP3634130B1 (en) * 2017-06-05 2025-10-15 Verdesian Life Sciences U.S., LLC Combination of pyroglutamic acid and a strobilurin fungicide for improved plant health effects
CN107573271B (zh) * 2017-08-11 2020-01-14 吴文君 一种氨基酸类化合物及其杀菌组合物与应用
CN107467029B (zh) * 2017-08-11 2021-02-19 西北农林科技大学 一种氨基酸类农用组合物
US20190070219A1 (en) * 2017-09-06 2019-03-07 King Bio, Inc. Homeopathic Nasal Gel, Swab, and Spray Formulations
KR20190045050A (ko) 2018-09-07 2019-05-02 류형준 감기 개선 식품조성물
EP3691449A1 (en) 2018-12-28 2020-08-12 Diversey, Inc. Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same
WO2021191297A1 (en) * 2020-03-25 2021-09-30 Universität Basel Virucidal hand cream formulation
CN111467338B (zh) * 2020-04-07 2021-04-23 中国科学院深圳先进技术研究院 焦谷氨酸在制备预防和治疗抗新冠肺炎新型冠状病毒的药物中的应用
JPWO2022044582A1 (no) * 2020-08-28 2022-03-03
US20240050512A1 (en) * 2020-11-25 2024-02-15 Phoxbio Limited Reduction of viral infections
CN112710651B (zh) * 2021-01-20 2023-10-13 浙江夸克生物科技有限公司 一种脂蛋白相关磷脂酶a2的测定试剂盒
KR20220110655A (ko) 2021-01-31 2022-08-09 (주)예스킨 코비드-19 항바이러스제 및 항바이러스제용 어주번트
KR102840063B1 (ko) 2021-01-31 2025-07-29 주식회사 케이팜스 코비드-19 항바이러스제
US12023399B2 (en) * 2021-06-30 2024-07-02 The Procter & Gamble Company Cleansing composition with pyrrolidone carboxylic acid
CN113956466B (zh) * 2021-11-05 2023-04-25 首都医科大学附属北京口腔医院 钛修饰双亲性高分子材料及其制备方法和其在制备口腔材料用修饰外泌体中的用途
KR102859468B1 (ko) * 2021-12-09 2025-09-15 가톨릭대학교 산학협력단 항균 및 항바이러스 조성물을 포함하는 세제, 포장재용 항균 및 항바이러스 조성물 및 항균 및 항바이러스 조성물을 포함하는 항균 제품
US12357551B2 (en) 2022-05-23 2025-07-15 The Procter & Gamble Company Antibacterial cleansing composition, uses and methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767788A (en) * 1978-08-14 1988-08-30 Sterling Drug Inc. Glutaric acid virucidal processes and compositions
JPS572690A (en) * 1980-06-05 1982-01-08 Kyowa Hakko Kogyo Co Ltd Preparation of l-proline by fermentation method
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
US4738847A (en) * 1985-01-14 1988-04-19 Kimberly-Clark Corporation Multi-ply virucidal product
JPS6422804A (en) * 1987-07-16 1989-01-25 Kanebo Ltd Sterilizing solution composition for wet tissue
US5244880A (en) * 1988-11-02 1993-09-14 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions
CA2003808C (en) * 1988-11-28 1999-11-09 Eugene Joseph Sehm Crosslinked polyacrylic acid
IE892257A1 (en) * 1989-07-13 1991-02-13 Elan Corp Anti-infective agent, process for its preparation and its¹use in therapy
FR2656523B1 (fr) * 1989-12-29 1992-05-07 Biorga Sa Labo Compositions pour l'usage cosmetique et/ou dermatologique, comprenant des pidolates metalliques.
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
DK0662814T3 (da) * 1992-09-29 1996-12-02 Henkel Kgaa Hårbehandlingsmiddel
FR2697161B1 (fr) * 1992-10-26 1995-01-13 Jouvance Daniel Produit cosmétique à potentiel redox stabilisé.
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis
JPH08133911A (ja) * 1994-11-04 1996-05-28 Senju Pharmaceut Co Ltd 抗菌組成物
DE19625982A1 (de) * 1996-06-28 1998-01-02 Wella Ag Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid

Also Published As

Publication number Publication date
JP2003512325A (ja) 2003-04-02
CN1379667A (zh) 2002-11-13
EP1242073A2 (en) 2002-09-25
HK1050475A1 (zh) 2003-06-27
DE60014163T2 (de) 2005-10-06
WO2001028556A2 (en) 2001-04-26
NO20021830D0 (no) 2002-04-18
JP2003512323A (ja) 2003-04-02
EP1225887A2 (en) 2002-07-31
CA2388802A1 (en) 2001-04-26
KR20020038945A (ko) 2002-05-24
PL355291A1 (en) 2004-04-05
ATE276749T1 (de) 2004-10-15
WO2001028552A3 (en) 2001-06-14
PL199782B1 (pl) 2008-10-31
RU2002113092A (ru) 2004-02-20
TR200201048T2 (tr) 2002-08-21
ES2223601T3 (es) 2005-03-01
WO2001028556A3 (en) 2001-10-11
AU1214701A (en) 2001-04-30
CZ20021374A3 (cs) 2002-08-14
HUP0204123A2 (hu) 2003-04-28
ZA200202475B (en) 2003-06-27
MXPA02003882A (es) 2002-10-23
RU2228177C2 (ru) 2004-05-10
CN101711761A (zh) 2010-05-26
DE60014163D1 (de) 2004-10-28
WO2001028552A2 (en) 2001-04-26
AU777549B2 (en) 2004-10-21
EP1242073B1 (en) 2004-09-22
BR0014778A (pt) 2002-07-16
CA2382985A1 (en) 2001-04-26
KR20020042729A (ko) 2002-06-05
CN1411372A (zh) 2003-04-16
HUP0204123A3 (en) 2003-05-28
AU8029700A (en) 2001-04-30
CA2388802C (en) 2007-09-11
NZ518117A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
NO20021830D0 (no) Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav
MY151199A (en) Substituted diphenyl heterocycles useful for treating hcv infection
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
NO961326D0 (no) Inhibitorer av
DE60119534D1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NO20041598L (no) Fremgangsmater for behandling eller profylakse av vaskulaer betennelse ved anvendelse av sterolabsorpsjonsinhibitor(er)
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
NO20061911L (no) Immunogene sammensetninger
ATE433963T1 (de) Fab-i inhibitoren
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
CA2408541A1 (en) Treating eczema and/or psoriasis
MX9805441A (es) Compuestos terapeuticos.
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE273011T1 (de) Zusammensetzung und verfahren zur behandlung von herpes simplex
ATE304365T1 (de) Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
WO2002083700A3 (en) Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
NO20030137L (no) Fremgangsmåte for behandling av ustabil angina pectoris
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
BR0015121A (pt) Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
GB9920673D0 (en) Treatment of allergic rhinitis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application